ArticleNeurobiology of disease2021

Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.

Shaunik Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.